Skip to content

Clinical trials

Phase 1/2 Glioblastoma trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Country / region: Israel Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20102
20112
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hadassah Medical Organization1
INSYS Therapeutics Inc1
Novartis Pharmaceuticals1
Radiation Therapy Oncology Group1
Soroka University Medical Center1
Vascular Biogenics Ltd. operating as VBL Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma6
Neoplasms2
Astrocytoma1
Central Nervous System Neoplasms1
Glioma1
Gliosarcoma1
Neoplasm Metastasis1
Neuroblastoma1
Recurrence1
Sarcoma1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.